Business Context and Reporting Period
InfuSystem Holdings, Inc. filed this Form 8-K on April 24, 2014, to disclose the entry into a Material Definitive Agreement. The Company, acting as Guarantor, and its wholly-owned subsidiary, First Biomedical, Inc., acting as Tenant, entered into a lease agreement for a new facility in Lenexa, Kansas, to replace existing leased facilities in Olathe, Kansas.
Key Financial Metrics and Agreement Terms
This filing details a specific lease agreement rather than general financial performance metrics such as revenue or profit. Key financial terms of the agreement include:
- Facility Size: 28,733 square feet of office, lab, and warehouse space.
- Lease Term: 147 months (12 years and 3 months) beginning on the date of occupation, with an expected commencement between July 1, 2014, and August 30, 2014.
- Leasehold Improvements: Total cost of approximately $856,376.00, to be paid by the Tenant in four installments:
- $263,864.00 upon execution.
- $296,256.00 thirty days post-execution.
- $237,004.80 upon the Commencement Date.
- $59,251.20 thirty days post-Commencement Date.
- Rent Schedule (Net Lease Rate):
- First 3 months: $0 per month.
- Months 4-39: $13,767.90 per month.
- Months 40-87: $14,821.44 per month.
- Months 88-123: $15,946.82 per month.
- Months 124-147: $17,167.97 per month.
- Estimated Additional Monthly Charges:
- CAM charges: $1,316.93.
- Real Estate Tax Assessment: $1,508.48.
- Lessor's Insurance Assessment: $215.50.
Material Changes and Renewal Options
The Company is consolidating or replacing its Olathe, KS facilities with a larger 28,733 square foot facility in Lenexa, KS. The lease includes an early termination option effective on the 7th anniversary, provided written notice is given at least 180 days prior. Additionally, the lease contains options to renew for two additional 5-year terms at fair market value rates, subject to specific notice deadlines.
Guidance, Outlook, and Risks
The filing does not provide general financial guidance, outlook, or management commentary regarding the Company's overall business strategy. The primary contingency noted is that the Commencement Date is dependent on the building being ready for occupancy and full use by the Tenant. The filing states that the description of the Lease is qualified in its entirety by reference to the full text of the Lease agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Verify the actual Commencement Date to confirm the start of the rent-free period and subsequent payment obligations.
- Review the full text of the Lease Agreement (Exhibit 10.1) for complete terms and conditions not summarized in this report.
- Assess the impact of the $856,376.00 leasehold improvement costs on the Company's immediate cash flow and liquidity.
- Monitor the Company's ability to meet the escalating rent schedule, which increases from $13,767.90 to $17,167.97 per month over the lease term.